Anti-Apolipoprotein A I antibody,Abcam,AB7613

This antibody has been used to determine that atherosclerotic lesions in the human aorta contain considerable amounts of lipoproteins. These lipoproteins were observed to be complexed with components of the extracellular matrix (especially LDL and proteoglycans). The role of these matrix-lipoprotein complexes is not entirely clear, however, animal models of atherosclerosis have shown that increased cellular proliferation and increased production of extracellular matrix components occur following injury to the intimal layer of the aorta.

Host

Goat

Reactivity

Human

Application

IHC-P, WB, ELISA, IP

Platform ID

BAB401085531

Abcam

Headquarters

Discovery Drive Cambridge Biomedical Campus Cambridge CB2 0AX UK

Contact

Tel: +44 (0)1223 696000
Fax: +44 (0)1223 215 215

Product Specifications
Scientific Background

Specifications

NameAnti-Apolipoprotein A I antibody
Cat. No.AB7613
HostGoat
IsotypeIgG
ReactivityHuman
ApplicationIHC-P, WB, ELISA, IP
ClonalityPolyclonal
Concentration1 mg/mL Batch dependent concentration
ImmunogenNative Full Length Protein corresponding to Human APOA1.
PurityAffinity purification Immunogen
Appearance/FormLiquid
ShippingBlue Ice
FormulationpH: 8 Preservative: 0.01% Sodium azide Constituents: 4.77% Sodium borate, 0.44% Sodium chloride, 0.15% EDTA
Storage-20°C
Regulatory StatusResearch Use Only

Scientific Background

Target data Participates in the reverse transport of cholesterol from tissues to the liver for excretion by promoting cholesterol efflux from tissues and by acting as a cofactor for the lecithin cholesterol acyltransferase (LCAT). As part of the SPAP complex, activates spermatozoa motility. See full target information APOA1

Category Paths

Request a product

Please provide the required information below so that we can quickly source your products.